No Data
No Data
U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk
Will Weakness in Cochlear Limited's (ASX:COH) Stock Prove Temporary Given Strong Fundamentals?
Macquarie Upgrades Cochlear to Neutral From Underperform, Price Target Is AU$289
Cochlear Affirms Up to 11% Underlying Net Profit Growth Guidance for Fiscal 2025
With 51% Institutional Ownership, Cochlear Limited (ASX:COH) Is a Favorite Amongst the Big Guns
Cochlear (ASX:COH) Will Want To Turn Around Its Return Trends
No Data
No Data